Clinical Trials Arena on MSN
How new technologies could transform clinical trial execution
The emergence of AI and biosensors offers a chance to address inefficiencies in drug development.
That's the audience that the London Business School is targeting with a new one-year MBA program. Unlike a traditional ...
As sensor data overwhelms the cloud, Innatera’s neuromorphic chips bring always-on, ultra-low-power AI directly to the edge. But how?
Some results have been hidden because they may be inaccessible to you
Show inaccessible results